Infection, inflammation and exercise in cystic fibrosis

Respiratory Research

Jeffrey Matthijn Beekman¹  Cornelis Korstiaan van der Ent²  Hubertus Gerardus Maria Arets²  Pauline Barbera van de Weert-van Leeuwen¹ 

[1] Centre for Molecular and Cellular Intervention, University Medical Center Utrecht, Utrecht, The Netherlands;Department of Paediatric Pulmonology, Cystic Fibrosis Centre, University Medical Centre Utrecht, Utrecht, the Netherlands

关键词: Respiratory system;    Lung disease;    Inflammation;    Infection;    Immune system;    Exercise;    Cytokines;   

Others  :  794942
DOI  :  10.1186/1465-9921-14-32

 received in 2012-10-24, accepted in 2013-02-17,  发布年份 2013

【 摘 要 】

Regular exercise is positively associated with health. It has also been suggested to exert anti-inflammatory effects. In healthy subjects, a single exercise session results in immune cell activation, which is characterized by production of immune modulatory peptides (e.g. IL-6, IL-8), a leukocytosis and enhanced immune cell functions. Upon cessation of exercise, immune activation is followed by a tolerizing phase, characterized by a reduced responsiveness of immune cells. Regular exercise of moderate intensity and duration has been shown to exert anti-inflammatory effects and is associated with a reduced disease incidence and viral infection susceptibility. Specific exercise programs may therefore be used to modify the course of chronic inflammatory and infectious diseases such as cystic fibrosis (CF).

Patients with CF suffer from severe and chronic pulmonary infections and inflammation, leading to obstructive and restrictive pulmonary disease, exercise intolerance and muscle cachexia. Inflammation is characterized by a hyper-inflammatory phenotype. Patients are encouraged to engage in exercise programs to maintain physical fitness, quality of life, pulmonary function and health.

In this review, we present an overview of available literature describing the association between regular exercise, inflammation and infection susceptibility and discuss the implications of these observations for prevention and treatment of inflammation and infection susceptibility in patients with CF.

【 授权许可】

   
2013 van de Weert - van Leeuwen et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Handschin C, Spiegelman BM: The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008, 454(7203):463-469.
• [2]Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A: Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116(9):1081-1093.
• [3]Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA: The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011, 11(9):607-615.
• [4]Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P: Position statement. Part one: Immune function and exercise. Exerc Immunol Rev 2011, 17:6-63.
• [5]Glaser R, Kiecolt-Glaser JK: Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005, 5(3):243-251.
• [6]Ploeger HE, Takken T, de Greef MHG, Timmons BW: The effect of chronic and acute exercise on different inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exerc Immunol Rev 2009, 15:6-41.
• [7]Mathur N, Pedersen BK: Exercise as a mean to control low-grade systemic inflammation. Mediators Inflamm 2008, 2008:109502.
• [8]Pedersen BK, Bruunsgaard H: Possible beneficial role of exercise in modulating low-grade inflammation in the elderly. Scand J Med Sci Sports 2003, 13(1):56-62.
• [9]Petersen AMW, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154-1162.
• [10]Flynn MG, McFarlin BK, Phillips MD, Stewart LK, Timmerman KL: Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women. J Appl Physiol 2003, 95(5):1833-1842.
• [11]O'Sullivan BP, Freedman SD: Cystic fibrosis. Lancet 2009, 373(9678):1891-1904.
• [12]Ratjen F, Doring G: Cystic fibrosis. Lancet 2003, 361(9358):681-689.
• [13]Rowe SM, Miller S, Sorscher EJ: Cystic fibrosis. N Engl J Med 2005, 352(19):1992-2001.
• [14]de Meer K, Gulmans VAM, Van der Laag J: Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999, 159:748-754.
• [15]Klijn PH, Van der Net J, Kimpen JL, Helders PJ, Van der Ent CK: Longitudinal determinants of peak aerobic performance in children with cystic fibrosis. Chest 2003, 124:2215-2219.
• [16]Lands LC, Heigenhauser GJ, Jones NL: Analysis of factors limiting maximal exercise performance in cystic fibrosis. Clin Sci (Colch) 1992, 83:391-397.
• [17]Moorcroft AJ, Dodd ME, Morris J, Webb AK: Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis. Eur Respir J 2005, 25:1050-1056.
• [18]Pianosi P, Leblanc J, Almudevar A: Relationship between FEV1 and peak oxygen uptake in children with cystic fibrosis. Pediatr Pulmonol 2005, 40(4):324-329.
• [19]Shah AR, Gozal D: Determinants of aerobic and anaerobic exercise performance in cystic fibrosis. Am J Respir Crit Care Med 1998, 157:1145-1150.
• [20]van de Weert-van Leeuwen PB, Slieker MG, Hulzebos HJ, Kruitwagen CL, Van der Ent CK, Arets HG: Chronic infection and inflammation affect exercise capacity in cystic fibrosis. Eur Respir J 2012, 39(4):893-898.
• [21]Bradley J, Moran F: Physical training for cystic fibrosis (review). Cochrane Database Syst Rev 2008, (1):CD002768.
• [22]Adams GR, Zaldivar FP, Nance DM, Kodesh E, Radom-Aizik S, Cooper DM: Exercise and leukocyte interchange among central circulation, lung, spleen, and muscle. Brain Behav Immunol 2011, 25(4):658-666.
• [23]Pedersen BK: The diseasome of physical inactivity–and the role of myokines in muscle–fat cross talk. J Physiol 2009, 587(Pt 23):5559-5568.
• [24]Hoene M, Weigert C: The stress response of the liver to physical exercise. Exerc Immunol Rev 2010, 16:163-183.
• [25]Brandt C, Pedersen BK: The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol 2010, 2010:520258.
• [26]Hilberg T, Deigner HP, Moller E, Claus RA, Ruryk A, Glaser D, Landre J, Brunkhorst FM, Reinhart K, Gabriel HH, Russwurm S: Transcription in response to physical stress–clues to the molecular mechanisms of exercise-induced asthma. FASEB J 2005, 19(11):1492-1494.
• [27]Radom-Aizik S, Zaldivar F Jr, Leu SY, Cooper DM: A brief bout of exercise alters gene expression and distinct gene pathways in peripheral blood mononuclear cells of early- and late-pubertal females. J Appl Physiol 2009, 107(1):168-175.
• [28]Carlson LA, Tighe SW, Kenefick RW, Dragon J, Westcott NW, Leclair RJ: Changes in transcriptional output of human peripheral blood mononuclear cells following resistance exercise. Eur J Appl Physiol 2011, 111(12):2919-2929.
• [29]Fischer CP: Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 2006, 12:6-33.
• [30]Booth S, Florida-James GD, McFarlin BK, Spielmann G, O'Connor DP, Simpson RJ: The impact of acute strenuous exercise on TLR2, TLR4 and HLA.DR expression on human blood monocytes induced by autologous serum. Eur J Appl Physiol 2010, 110(6):1259-1268.
• [31]Zinyama RB, Bancroft GJ, Sigola LB: Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology 2001, 104(4):439-446.
• [32]Sigola LB, Zinyama RB: Adrenaline inhibits macrophage nitric oxide production through beta1 and beta2 adrenergic receptors. Immunology 2000, 100(3):359-363.
• [33]Szelenyi J, Selmeczy Z, Brozik A, Medgyesi D, Magocsi M: Dual beta-adrenergic modulation in the immune system: stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages. Neurochem Int 2006, 49(1):94-103.
• [34]Pekarova M, Kralova J, Kubala L, Ciz M, Papezikova I, Macickova T, Pecivova J, Nosal R, Lojek A: Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors. J Physiol Pharmacol 2009, 60(1):143-150.
• [35]Fischer CP, Plomgaard P, Hansen AK, Pilegaard H, Saltin B, Pedersen BK: Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab 2004, 287:E1189-E1194.
• [36]Davis JM, Kohut ML, Colbert LH, Jackson DA, Ghaffar A, Mayer EP: Exercise, alveolar macrophage function, and susceptibility to respiratory infection. J Appl Physiol 1997, 83(5):1461-1466.
• [37]Lowder T, Padgett DA, Woods JA: Moderate exercise protects mice from death due to influenza virus. Brain Behav Immun 2005, 19(5):377-380.
• [38]Murphy EA, Davis JM, Brown AS, Carmichael MD, Rooijen N, Ghaffar A, Mayer EP: Role of lung macrophages on susceptibility to respiratory infection following short-term moderate exercise training. Am J Physiol Regul Integr Comp Physiol 2004, 287:1354-1358.
• [39]Sim YJ, Yu S, Yoon KJ, Loiacono CM, Kohut ML: Chronic exercise reduces illness severity, decreases viral load, and results in greater anti-inflammatory effects than acute exercise during influenza infection. J Infect Dis 2009, 200(9):1434-1442.
• [40]Nieman DC, Henson DA, Austin MD, Sha W: Upper respiratory tract infection is reduced in physically fit and active adults. Br J Sports Med 2011, 45(12):987-992.
• [41]Lin J, Handschin C, Spiegelman BM: Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005, 1(6):361-370.
• [42]Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C: Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 2003, 85(2–5):267-273.
• [43]Sternberg EM: Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006, 6(4):318-328.
• [44]Irwin MR, Cole SW: Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 2011, 11(9):625-632.
• [45]Boron WF, Boulpaep EL: Medical physiology. Philadelphia: Elsevier Science; 2003.
• [46]Glass CK, Saijo K: Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol 2010, 10(5):365-376.
• [47]Canto C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR, Auwerx J: Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 2010, 11(3):213-219.
• [48]Koulmann N, Bigard AX: Interaction between signalling pathways involved in skeletal muscle responses to endurance exercise. Pflugers Arch 2006, 452(2):125-139.
• [49]Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G: PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007, 6(2):137-143.
• [50]Cohen TS, Prince A: Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 2012, 18(4):509-519.
• [51]Ratner D, Mueller C: Immune responses in cystic fibrosis: are they intrinsically defective? Am J Respir Cell Mol Biol 2012, 46(6):715-722.
• [52]Dekkers JF, Van der Ent CK, Kalkhoven E, Beekman JM: PPARgamma as a therapeutic target in cystic fibrosis. Trends Mol Med 2012, 18(5):283-291.
• [53]Hebestreit H, Kieser S, Rudiger S, Schenk T, Junge S, Hebestreit A, Ballmann M, Posselt HG, Kriemler S: Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J 2006, 28(4):734-739.
• [54]Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, Gosselink R, Decramer M, Dupont L: Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009, 33(1):99-106.
• [55]Reid MB, Moylan JS: Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J Physiol 2011, 589(Pt 9):2171-2179.
• [56]Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM: Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006, 61(1):17-22.
• [57]Divangahi M, Balghi H, Danialou G, Comtois AS, Demoule A, Ernest S, Haston C, Robert R, Hanrahan JW, Radzioch D, Petrof BJ: Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 2009, 5(7):e1000586.
• [58]Lamhonwah AM, Bear CE, Huan LJ, Kim CP, Ackerley CA, Tein I: Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 2010, 67(6):802-808.
• [59]Becq F: CFTR channels and adenosine triphosphate release: the impossible rendez-vous revisited in skeletal muscle. J Physiol 2010, 588(Pt 23):4605-4606.
• [60]Tu J, Le G, Ballard HJ: Involvement of the cystic fibrosis transmembrane conductance regulator in the acidosis-induced efflux of ATP from rat skeletal muscle. J Physiol 2010, 588(Pt 22):4563-4578.
• [61]Kaplan TA, Moccia-Loos G, Rabin M, McKey RM Jr: Lack of effect of delta F508 mutation on aerobic capacity in patients with cystic fibrosis. Clin J Sport Med 1996, 6(4):226-231.
• [62]Selvadurai HC, McKay KO, Blimkie CJ, Cooper PJ, Mellis CM, Van Asperen PP: The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am J Respir Crit Care Med 2002, 165:762-765.
• [63]Schmitt L, Wiebel M, Frese F, Dehnert C, Zugck C, Bartsch P, Mairbaurl H: Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma. Eur Respir J 2011, 37(2):342-348.
• [64]Hebestreit A, Kersting U, Basler B, Jeschke R, Hebestreit H: Exercise inhibits epithelial sodium channels in patients with cystic fibrosis. Am J Respir Care Med 2001, 164(3):443-446.
• [65]Dwyer TJ, Elkins MR, Bye PT: The role of exercise in maintaining health in cystic fibrosis. Curr Opin Pulm Med 2011, 17(6):455-460.
• [66]Rand S, Prasad SA: Exercise as part of a cystic fibrosis therapeutic routine. Expert Rev Respir Med 2012, 6(3):341-351.
• [67]Nixon PA, Orenstein DM: The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992, 327(25):1785-1788.
• [68]van Doorn N: Exercise programs for children with cystic fibrosis: A systematic review of randomized controlled trials. Disabil Rehabil 2009, 26:1-9.
• [69]Blau H, Mussaffi-Georgy H, Fink G, Kaye C, Szeinberg A, Spitzer SA, Yahav J: Effects of an intensive 4-week summer camp on cystic fibrosis: pulmonary function, exercise tolerance, and nutrition. Chest 2002, 121(4):1117-1122.
• [70]Klijn PH, Oudshoorn A: Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest 2004, 125(4):1299-1305.
• [71]Schmitz TG, Goldbeck L: The effect of inpatient rehabilitation programmes on quality of life in patients with cystic fibrosis: a multi-center study. Health Qual Life Outcomes 2006, 4:8. BioMed Central Full Text
• [72]Gruber W, Orenstein DM, Braumann KM, Huls G: Health-related fitness and trainability in children with cystic fibrosis. Pediatr Pulmonol 2008, 43(10):953-964.
• [73]Selvadurai HC, Blimkie CJ, Meyers N, Mellis CM, Cooper PJ, Van Asperen PP: Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol 2002, 33(3):194-200.
• [74]Schneiderman-Walker J, Pollock SL, Corey M, Wilkes DD, Canny GJ, Pedder L, Reisman JJ: A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr 2000, 136(3):304-310.
• [75]Cerny FJ: Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis. Phys Ther 1989, 69(8):633-639.
• [76]Boas SR, Danduran MJ, McColley SA, Beaman K, O'Gorman MRG: Immune modulation following aerobic exercise in children with cystic fibrosis. Int J Sports Med 1999, 21:294-301.
• [77]Boas SR, Danduran MJ, McBride AL, McColley SA, O'Gorman MRG: Postexercise immune correlates in children with and without cystic fibrosis. Med Sci Sports Exerc 2000, 32(12):1997-2004.
• [78]Tirakitsoontorn P, Nussbaum E, Moser C, Hill M, Cooper DM: Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis. Am J Respir Crit Care Med 2001, 164:1432-1437.
• [79]Ionescu AA, Mickleborough TD, Bolton CE, Lindley MR, Nixon LS, Dunseath G, Luzio S, Owens DR, Shale DJ: The systemic inflammatory response to exercise in adults with cystic fibrosis. J Cyst Fibros 2006, 5:105-112.
• [80]Pastva A, Estell K, Schoeb TR, Atkinson TP, Schwiebert LM: Aerobic exercise attenuates airway inflammatory responses in a mouse model of atopic asthma. J Immunol 2004, 172(7):4520-4526.
• [81]Vieira RP, Claudino RC, Duarte AC, Santos AB, Perini A, Faria Neto HC, Mauad T, Martins MA, Dolhnikoff M, Carvalho CR: Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice. Am J Respir Crit Care Med 2007, 176(9):871-877.
• [82]Moeller A, Stampfli SF, Rueckert B, Rechsteiner T, Hamacher J, Wildhaber JH: Effects of a short-term rehabilitation program on airway inflammation in children with cystic fibrosis. Pediatr Pulmonol 2010, 45(6):541-551.
• [83]Nikolaizik WH, Simon HU, Iseli P, Blaser K, Schoni MH: Effect of 3 weeks' rehabilitation on neutrophil surface antigens and lung function in cystic fibrosis. Eur Respir J 2000, 15(5):942-948.